{"nct_id":"NCT00736970","title":"Oral Deforolimus With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer (8669-009)","status":"COMPLETED","status_verified_date":"2015-08","start_date":"2008-07","start_date_type":null,"primary_completion_date":"2011-01","primary_completion_date_type":"ACTUAL","completion_date":"2011-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}